Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 27 05 2020
pubmed: 20 10 2020
medline: 3 9 2021
entrez: 19 10 2020
Statut: ppublish

Résumé

The long-term risk of type 2 diabetes in adolescents with nonalcoholic fatty liver disease (NAFLD) is unclear. To assess type 2 diabetes risk among adolescents with NAFLD. A nationwide, population-based study of Israeli adolescents who were examined before military service during 1997-2011 and were followed until December 31, 2016. A total of 1 025 796 normoglycemic adolescents were included. Biopsy or radiographic tests were prerequisite for NAFLD diagnosis. Data were linked to the Israeli National Diabetes Registry. Type 2 diabetes incidence. During a mean follow-up of 13.3 years, 12 of 633 adolescents with NAFLD (1.9%; all with high body mass index [BMI] at baseline) were diagnosed with type 2 diabetes compared with 2917 (0.3%) adolescents without NAFLD. The hazard ratio (HR) for type 2 diabetes was 2.59 (95% confidence interval [CI], 1.47-4.58) for the NAFLD vs. the non-NAFLD group after adjustment for BMI and sociodemographic confounders. The elevated risk persisted in several sensitivity analyses. These included an analysis of persons without other metabolic comorbidities (adjusted HR, 2.75 [95% CI, 1.48-5.14]) and of persons with high BMI; and an analysis whose outcome was type 2 diabetes by age 30 years (adjusted HR, 2.14 [95% CI, 1.02-4.52]). The results remained significant when a sex-, birth year-, and BMI-matched control group was the reference (adjusted HR, 2.98 [95% CI, 1.54-5.74]). Among normoglycemic adolescents, NAFLD was associated with an increased adjusted risk for type 2 diabetes, which may be apparent before age 30 years.

Identifiants

pubmed: 33075820
pii: 5930840
doi: 10.1210/clinem/dgaa753
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34-e44

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Aya Bardugo (A)

Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Cole D Bendor (CD)

Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Inbar Zucker (I)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel.

Miri Lutski (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel.

Tali Cukierman-Yaffe (T)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Estela Derazne (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ofri Mosenzon (O)

The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Dorit Tzur (D)

Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Zivan Beer (Z)

Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Orit Pinhas-Hamiel (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Michal Ben-Ami (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Boris Fishman (B)

Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Internal Medicine D and Hypertension Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Dana Ben-Ami Shor (D)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Gastroenterology, Tel-Aviv Medical Center, Tel Aviv, Israel.

Itamar Raz (I)

The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Arnon Afek (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Central Management, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Hertzel C Gerstein (HC)

Department of Medicine, McMaster University Hamilton, Ontario, Canada.

Hans-Ulrich Häring (HU)

Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.
Institute of Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research, Tübingen, Germany.

Amir Tirosh (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Zohar Levi (Z)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Gastroenterology Department, Rabin Medical Center, Petach Tikva, Israel.

Gilad Twig (G)

Department of Military Medicine, Hebrew University, Jerusalem and the Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH